Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

uPA Inhibitor Inhibitor (CAS 149732-36-5)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
4-iodo-1-benzothiophene-2-carboximidamide hydrochloride
Application:
uPA Inhibitor is a substrate-competetive inhibitor of uPA, trypsin, and tryptase
CAS Number:
149732-36-5
Molecular Weight:
338.6
Molecular Formula:
C9H7IN2S•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

uPA Inhibitor is a cell-permeable carboxamidine compound reported to act as a potent, substrate-competitive inhibitor of uPA (Ki = 0.32μM), trypsin (Ki = 0.44 μM), and tryptase (Ki = 1.5 µM). This compound is also reported to have good selectivity relative to tPA, Thrombin, and Factor Xa. Additionally reported to block cell surface uPA-mediated, plasminogen-dependent degradation of fibronectin by HT1080 cells in a dose-dependent manner (IC50 = 540 nM).


uPA Inhibitor Inhibitor (CAS 149732-36-5) References

  1. Structural basis for selectivity of a small molecule, S1-binding, submicromolar inhibitor of urokinase-type plasminogen activator.  |  Katz, BA., et al. 2000. Chem Biol. 7: 299-312. PMID: 10779411
  2. Urokinase-type plasminogen activator: a potent marker of metastatic potential in human cancers.  |  Duffy, MJ. 2002. Biochem Soc Trans. 30: 207-10. PMID: 12023852
  3. Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer.  |  Harbeck, N., et al. 2004. Thromb Haemost. 91: 450-6. PMID: 14983219
  4. Dissecting and designing inhibitor selectivity determinants at the S1 site using an artificial Ala190 protease (Ala190 uPA).  |  Katz, BA., et al. 2004. J Mol Biol. 344: 527-47. PMID: 15522303
  5. Identification of a novel inhibitor of urokinase-type plasminogen activator.  |  Zhu, M., et al. 2007. Mol Cancer Ther. 6: 1348-56. PMID: 17431113
  6. Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle.  |  Beaulieu, LM., et al. 2007. Bioessays. 29: 1029-38. PMID: 17876797
  7. Urokinase plasminogen activator and its inhibitor type-1 as prognostic factors in differentiated thyroid carcinoma patients.  |  Horvatic Herceg, G., et al. 2013. Otolaryngol Head Neck Surg. 149: 533-40. PMID: 23835563
  8. The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single target.  |  O'Halloran, TV., et al. 2013. Theranostics. 3: 496-506. PMID: 23843897
  9. Synthesis and in vivo preclinical evaluation of an (18)F labeled uPA inhibitor as a potential PET imaging agent.  |  Ides, J., et al. 2014. Nucl Med Biol. 41: 477-87. PMID: 24768145
  10. Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.  |  Xu, P., et al. 2017. Int J Biol Sci. 13: 1222-1233. PMID: 29104489
  11. Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis.  |  Islam, I., et al. 2018. Bioorg Med Chem Lett. 28: 3372-3375. PMID: 30201291
  12. Disruption of Water Networks is the Cause of Human/Mouse Species Selectivity in Urokinase Plasminogen Activator (uPA) Inhibitors Derived from Hexamethylene Amiloride (HMA).  |  S El Salamouni, N., et al. 2022. J Med Chem. 65: 1933-1945. PMID: 34898192
  13. The synthesis of three 4-substituted benzo[b]thiophene-2-carboxamidines as potent and selective inhibitors of urokinase.  |  Bridges, AJ., et al. 1993. Bioorg Med Chem. 1: 403-10. PMID: 8087561
  14. Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor.  |  Towle, MJ., et al. 1993. Cancer Res. 53: 2553-9. PMID: 8495419
  15. Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).  |  Rabbani, SA., et al. 1995. Int J Cancer. 63: 840-5. PMID: 8847143

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

uPA Inhibitor, 5 mg

sc-356184
5 mg
$311.00